Glycopyrrolate Injection
Product Images NDC 71872-7093

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 01)

Chemical structure of glycopyrrolate shown as a molecular diagram with the formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

1 mL Vial Label (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 02)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL in 1 mL single dose vial. It is indicated for intramuscular or intravenous administration and contains benzyl alcohol. The label includes a warning: 'Not for use in newborns.' Manufactured by Wintac Limited, India, and for Somerset Therapeutics LLC, Mendham, NJ, with NDC 70069-011-01.*

FDA Label Image

Pdp (7093)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL, in a 1 mL single-dose vial. The label indicates intramuscular or intravenous use and contains benzyl alcohol as a preservative. It includes storage instructions at 20°C to 25°C and mentions it is repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.